Challenges in implementing antimicrobial stewardship (AMS) in organ transplant centers in India [0.03%]
印度器官移植中心实施抗菌药物管理（AMS）的挑战
Abdul Ghafur,Nitin Bansal
Abdul Ghafur
Introduction: We, in India, have unique challenges in implementing antimicrobial stewardship (AMS) in our institutions, especially the transplant settings. Identifying challenges, addressing them, and finding innovative s...
COVID-19 vaccine effectiveness in patients with hematologic malignancy [0.03%]
血液系统恶性肿瘤患者的Covid-19疫苗效力
Dimpy P Shah,Pankil K Shah,Michael A Thompson
Dimpy P Shah
COVID‐19 vaccine response → HMsolidVaccine effectiveness → Population studies urgently neededEarly #COVID19CP could be lifesaving in immunocompromised HM pts This article is protected by copyright. All rights reserv...
Importance of antimicrobial stewardship in solid organ transplant recipients: An ESCMID perspective [0.03%]
欧洲抗菌药物管理协会(ESCMID)关于器官移植受者抗菌药物合理应用的重要观点和建议
Petros Ioannou,Stamatis Karakonstantis,Jeroen Schouten et al.
Petros Ioannou et al.
Background: In the last decades, solid organ transplantation (SOT) has emerged as an important method in the management of chronic kidney, liver, heart, and lung failure. Antimicrobial use has led to a significant reducti...
Chiara Adembri,Erida Nure,Lorenzo Tofani et al.
Chiara Adembri et al.
Liver transplantation from active COVID-19 donors: Is it ethically justifiable? [0.03%]
活动性新冠肺炎供肝器官移植：伦理上说得过去吗？
Alessandra Agnese Grossi,Federico Nicoli,Massimo Cardillo et al.
Alessandra Agnese Grossi et al.
The debate on the opportunity to use organs from donors testing positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in recipients with naïve resolved or active COVID-19 is ongoing. We aim to present the ethical analys...
Current state of antimicrobial stewardship and organ transplantation in Spain [0.03%]
西班牙抗菌药物管理和器官移植的现状
Jose Tiago Silva,José María Aguado
Jose Tiago Silva
Introduction: Solid-organ transplantation (SOT) remains the best therapeutic option for end-stage organ disease. Regrettably, SOT recipients are disproportionately affected by nosocomial infections produced by multidrug-r...
Isoniazid prophylaxis in liver transplant recipient with latent tuberculosis: Is it harmful for transplanted liver? [0.03%]
肝移植受者潜伏结核感染的一线预防方案异烟肼对移植肝是否有害？
Seiyed Mohammad Ali Ghayumi,Alireza Shamsaeefar,Nasrin Motazedian et al.
Seiyed Mohammad Ali Ghayumi et al.
Background: Liver transplantation (LT) is considered the only treatment for patients with end-stage liver disease and, despite its incredible impacts on the patients' health status, places them in an immunocompromised sta...
Impact of solid organ transplant status on outcomes of hospitalized patients with COVID-19 infection [0.03%]
实体器官移植状态对COVID-19住院患者预后的影响
Joanna Schaenman,Hannah Byford,Tristan Grogan et al.
Joanna Schaenman et al.
Background: The COVID-19 pandemic has caused significant morbidity and mortality in solid organ transplant (SOT) recipients. However, it remains unclear whether the risk factor for SOT patients is the immunosuppression in...
COVID-19 pandemic deteriorates aftercare attendance in heart transplant recipients independently of perceived impact on social life [0.03%]
新冠疫情恶化了心脏移植受者的术后随访独立于对社交生活影响的感知
Daniel Oehler,Raphael Romano Bruno,Malte Kelm et al.
Daniel Oehler et al.
Background: Heart transplant (HTx) recipients are at an increased risk of developing infections or malignancies due to immunosuppressive medication. Thus, regular aftercare in those patients is of utmost importance. The e...
Impact of COVID-19 on living donor liver and kidney transplantation programs in Japan in 2020 [0.03%]
2020年日本新冠疫情对肝肾移植活体供肝/肾获取的影响分析
Kaori Kuramitsu,Shigeyoshi Yamanaga,Ryosuke Osawa et al.
Kaori Kuramitsu et al.
Background: Although many transplant programs have been forced to suspend living donor transplants due to the emergence of coronavirus disease (COVID-19), there are relatively few real-time databases to assess center-leve...